Endocrine Disorders: Evaluation and Management
Summary
- American Diabetes Association recommends that patients with diabetes achieve a hemoglobin A1c of around or below 7% (Management Guidelines)[ADA Guidelines]
- Because of the inaccuracy of hemoglobin A1c in HIV-infected patients,[Diop 2006; Kim 2009] a lower target for glycemic control, such as 6.5%, is reasonable if the patient is not experiencing significant hypoglycemia
- Glycemic monitoring should be performed every 3-4 months, and patients should be aware of their results and the treatment goals
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Diabetes, Endocrine Disorders